by admin
Comments Off

California Biomedical Industry 2012 Report: “are looking beyond California’s and our nation’s borders to countries with more certain regulatory pathways, regions with financial incentives and easier access to capital, and expanding markets…”

Click on this link for a message from our sponsor … Three major areas reflecting government policy are compounding investors’ apprehensions. •Regulatory risk at the U.S. Food and Drug Administration. A 2011 report from the California Healthcare Institute and Boston … Continue reading